2,019
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Preparation, characterization, and in vitro release of new transdermal methimazole as alternative to oral delivery

, , &
Pages 1-10 | Received 30 Oct 2007, Accepted 16 Jan 2008, Published online: 01 Jan 2009

References

  • Bashford R, Horrigan JP 2000. Progesterone organogel for premenstrual dysphoric disorder [letter]. J. Am. Acad. Child Adol. Psychiatry 39, 546–547.
  • Becker TJ, Graves TK, Kruger JM, Braselton WE, Nachreiner RF 2000. Effects of methimazole on renal function in cats with hyperthyroidism. J. Am. Anim. Hosp. Assoc. 36, 215–23.
  • Bennett N, Papich MG, Hoenig M, Fettman MJ, Lappin MR 2005. Evaluation of transdermal application of glipizide in a pluronic lecithin gel to healthy cats. 66, 581–588.
  • Bromberg LE, Ron ES 1998. Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery. Adv. Drug Deliv. Rev. 31, 197–221.
  • Broussard JD, Peterson ME, Fox PR 1995. Changes in clinical and laboratory findings in cats with hyperthyroidism form 1983 to 1993. J. Am. Vet. Med. Assoc. 206, 302–305.
  • Buijtels JJCWM, Kurvers IAPG, Galac S, Winter EA, Kooistra HS 2006. Trasdermal carbimazole gel for the treatment of feline hyperthyroidism. 16th ECVIM Annual Congress, 14–16 September Amsterdam.
  • Chen-Chow P, Frank SG 1981. In vitro release of lidocaine from Pluronic F-127 gels. Int. J. Pharm. 8, 89–99.
  • Chu B, Zhou Z 1996. Nonionic surfactants: polyoxyalkylene block copolymer. ed. Nace VM 67–143. New York, Marcel Dekker.
  • Ciribassi J, Luescher A, Pasloske K, et al 2003. Comparative bioavailability of fluoxetine after transdermal and oral administration to healthy cats. Am. J. Vet. Res. 64, 994–998.
  • Desai SD, Blanchard J 1998. In vitro evaluation of Pluronic F-127 based controlled-release ocular delivery systems for pilocarpine. J. Pharm. Sci. 87, 226–230.
  • Dempski RE, Portnoff JB, Wase AW 1969. In vitro release and in vivo penetration studies of a topical steroid from nonaqueous vehicles. J. Pharm. Sci. 58, 579.
  • Flanders JA 1994. Surgical therapy of the thyroid. Vet. Clin. North Am. Small Anim. Pract. 24, 607–621.
  • Franckum J, Ramsay D, Das NG, Das SK 2004. Pluronic lecithin organogel for local delivery of anti-inflammatory drugs. Int. J. Pharmaceut. Compounding 8, 101–105.
  • Franz TJ 1975. Percutaneous absorption on the relevance of in vitro data. J. Invest. Dermatol. 64, 190–195.
  • Gallardo V, Muñoz M, Ruíz MA 2005. Formulations of hydrogels and lipogels with vitamin E. J. Cosmet. Dermatol. 4, 187–192.
  • Gary M, Heir DMD 2004. Diagnosis and management of trigeminal neuralgia and chronic paroxysmal hemicrania in a 43 year old woman. Oral and transmucosal paharmacologic medications. Int. J. Pharmaceut. Compounding 8 (5), 337–343.
  • Grace D, Rogers J, Skeith K, Anderson K 1999. Topical diclofenaco versus placebo: a double blind, randomised clinical trial in patients with osteoarthritis of the knee. J. Rheum. 26, 2659–2663.
  • Giordano J, Daleo C, Sacks SM 1998. Topical ondasetron attenuates nociceptive and inflammatory effects of intradermal capsaicin in humans. Eur. J. Pharmacol. 354, 13–14.
  • Hayat MA 1989. Principles and Techniques of Electron Microscopy. Biological Applications. 3rd edition. 251–252. Macmillan Press.
  • Hoffmann G, Marks SL, Taboada J, Hosgood-Pagel G, Wofsheimer KL 2003. Topical methimazole treatment in cats whith hyperthyroidism. J. Feline Med. Surg. 5, 77–82.
  • Hoffman SB, Yoder AR, Trepanier LA 2002. Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats. J. Vet. Pharmacol. Ther. 25(3), 189–193.
  • Idson B. 1983. Vehicle effects in percutaneous absorption. Drug Metab. Rev. 14, 207–222.
  • Kierstan KT, Beezer AE, Mitchell JC, Hadgraft J, Raghavan SL, Davis AF 2001. UV-spectrophotometry study of membrane transport processes with a novel diffusion cell. Int. J. Pharm. 229, 87–94.
  • Kim SW, Jeong B, Bae YH, Lee DS 1997. Nature 388, 860–862.
  • Krotscheck U, Boothe D, Boothe H 2004. Evaluation of transdermal morphine and fentanyl pluronic lecithin organogel administration in dogs. Vet. Therapeut. 5, 202–217.
  • Lecuyer M, Prini S, Dunn ME, Doucet MY 2006. Clinical efficacy and safety of transdermal methimazole in the treatment feline hyperthyroidism. Can. Vet. J. 47 (2), 131–135.
  • Martín MC 2005. Introducción a la Dermofarmacia y Cosmetología. Ediciones Acribia. Zaragoza, 29–35.
  • McCarron PA, Woolfson AD, Keating SM 2000. Sustained release of 5-fluorouracil from polymeric nanoparticles. J. Pharm. Pharmacol. 52, 1451–1459.
  • Mealey K, Peck K, Bennett B, et al. 2004. Systemic absorption of amitriptyline and buspirone after oral and transdermal administration to healthy cats. J. Vet. Intern. Med. 18, 43–46.
  • Morales ME, Gallardo V, Calpena AC, Doménech J, Ruiz MA 2004. Comparative study of morphine diffusion from sustained release polymeric suspensions. J. Control. Rel. 95, 75–81.
  • Murdan S 2005. A review of plironic lecithin organogels as a topical and transdermal drug delivery system. Hosp. Pharmacist 12, 267–270.
  • Narendra B, Randolph TW, Cleland JL 1994. Stability of protein formulations: Investigation of surfactant effects by a novel EPR spectroscopic technique. Pharmateut. Res. 12, 2–11.
  • Parra J, Pons Gimier JL 1995. Ciencia cosmética: bases fisiológicas y criterios prácticos edit. 581–608. Consejo General de Colegios Oficiales de Farmacéuticos de Madrid.
  • Peterson ME, Kintzer PP, Hurvitz AI 1988. Methimazole treatment of 262 cats with hyperthyoridism. J. Vet. Intern. Med. 2, 150–157.
  • Peterson ME, Melián C, Nichols CE 2001. Measurement of serum concentrations of free thyroxine, total thyroxine, and total triiodothyronine in cats with hyperthyroidism and cats with nonthyroidaldisease. J. Am. Vet. Med. Assoc. 218, 529–536.
  • Poulsen BJ, Young E, Coquita V 1968. Effect of topical vehicle composition on the in vitro release of fluocinolone acetonide and its acetate esters. J. Pharm. Sci., 57 928–933.
  • Rigano L, Siguri S 1996. Análisis sensoriales: un instrumento para determinar la calidad en cosmética NCP 215, 5–9.
  • Sambhaji P, Vijay S, Kakasaheb M, Shivajirao K 2004. Effect of organogel components on in vitro nasal delivery of propranolol hydrochloride. AAPS Pharm. Sci. Tech. 5(4), article 63.
  • Sartor LL, Trepanier LA, Kroll MM, Rodan I, Challoner L 2004. Efficacy and safety of transdermal methimazole in the treatment of cats with hyperthyroidism. J. Vet. Intern. Med. 18, 651–655.
  • Sharma PK, Matthew JE, Bhaitia SR 2005. Structure and assembly of PEO-PPO-PEO co-polymers in mammalian cell-culture media. J. Biomater. Sci. Polym. Ed. 16(9), 1139–1151.
  • Sweetman SC 2003. Martindale: Guía completa de consulta Farmacoterapéutica. 1st ed. 1602–1603. Española, Pharmaceutical Press, Barcelona.
  • Trepanier LA, Hoffman SB, Kroll M, Rodan I, Challoner L 2003. Efficacy and safety of once versus twice daily administration of methimazole in cats with hyperthyroidism. J. Am. Vet. Med. Assoc. 222, 954–958.
  • Vadnere M, Amidon G, Lindenbaum S, Haslam JL 1984. Thermodynamic studies on the gel-sol transition of some pluronic polyols. Inter. J. Pharmaceut. 22, 207–218.
  • Valenta C, Wanka M, Heidlas J 2000. Evaluation of a novel soya-lecithin formulations for dermal use containing ketoprofen as a model drug. J. Control. Rev. 63, 165–173.
  • Valljakka-Koskela R, Kirjavainen M, Mönkkönen J, Urtti A, Kiesvaara J 1998. Enhancement of percutaneous absortion of naproxer by phospholipids. Int. J. Pharm. 175, 225–230.
  • Willis-Goulet H, Schmidt B, Nicklin C, et al. 2003. Comparison of serum dexamethasone in cats after oral or transdermal administration using PLO: a pilot study. Vet. Dermatol. 14, 83–89.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.